Lipoproteins and Cardiovascular Health

Работ: 76

1. ASSOTIATION OF THE GENETIC POLYMORPHISM E670G OF THE PCSK-9 AND THE SEVERITY OF THE CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN UZBEK POPULATION

   Rano B. Alieva, Shavkat U. Hoshimov, Sh. S. Ahmedova +3

   СтатьяLipoproteins and Cardiovascular HealthEurasian heart journal2019Цитирований: 0

   ABIABI:AkademIndex/openalex/2019.article.001033

2. STATINS IN ACUTE CORONARY SYNDROMES

   A. L. Alyavi, S. R. Kenjaev, D. A. Alimov +4

   СтатьяLipoproteins and Cardiovascular HealthEurasian heart journal2019Цитирований: 0

   ABIABI:AkademIndex/openalex/2019.article.002150

3. EFFECT OF ATORVASTATIN ON THE FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS WITH ACUTE CORONARY SYNDROME WHO UNDERWENT PERCUTANEOUS CORONARY ANGIOPLASTY

   S. K. Abdusattarova, Ali Alavy, S. R. Kenjaev

   СтатьяLipoproteins and Cardiovascular HealthDOAJ (DOAJ: Directory of Open Access Journals)2019Цитирований: 0

   ABIABI:AkademIndex/openalex/2019.article.002250

4. Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations

   Dennis T. Ko, Atul Sivaswamy, Maneesh Sud +11

   СтатьяLipoproteins and Cardiovascular HealthCanadian Medical Association Journal2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.000046

5. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI

   Jamol Uzokov, Bakhromkhon Alyavi, A. Abdullaev

   СтатьяLipoproteins and Cardiovascular HealthAtherosclerosis2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.000604

6. Modern Hypolipidemic Therapy in Patients with Arterial Hypertension with High Cardiovascular Risk Under Conditions of Long-Term Ambulatory Observation

   Ruziyeva Amira Asrorovna, Muradova Railya Rustamovna, Turaev Khikmatulla Negmatovich +1

   СтатьяLipoproteins and Cardiovascular HealthInternational Journal of Current Research and Review2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.000785

7. Evaluation of the comparative effectiveness of rosuvastatin and atorvastatin in patients with heart failure

   U. K. Kamilova, Nuriddin Nuritdinov

   СтатьяLipoproteins and Cardiovascular HealthAtherosclerosis2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.000823

8. Prognostic signs of an unfavorable course of coronary heart disease in patients with type 2 diabetes mellitus

   Yu.М. Urmanova, Sh.Sh. Mukhtarova, Ashley Grossman +2

   СтатьяLipoproteins and Cardiovascular HealthINTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.003093

9. Prevalence and Features of Aspirin Resistance in Patients with Coronary Artery Disease

   Khodjanova SH

   СтатьяAntiplatelet Therapy and Cardiovascular DiseasesCross Current International Journal of Medical and Biosciences2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.005217

10. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +6

    ПрепринтLipoproteins and Cardiovascular HealthResearch Square2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.preprint.000048

11. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, George Giannakoulas +1

    ПрепринтLipoproteins and Cardiovascular HealthResearch Square2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.preprint.000099

12. Aspirin Resistance in Patients with Chronic Coronary Syndrome

    A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.002392

13. Modern Approach to Non-Drug Treatment of Dyslipidemia

    M N Badridinnova, D E Tursunova

    СтатьяLipoproteins and Cardiovascular Health2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.008514

14. EFFECTIVENESS OF ANTIHYPERTENSIVE DRUG THERAPY IN OUTPATIENT PATIENTS WITH CARDIOVASCULAR DISEASES AND SEVERE LIPID METABOLISM DISORDERS

    M N Badridinnova, Tursunova D. E

    СтатьяLipoproteins and Cardiovascular Health2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.010301

15. Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

    Jamol Uzokov

    ДругоеLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.other.000002

16. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

    Krzysztof J. Filipiak‬, Miguel Camafort, Matteo Cameli +9

    СтатьяLipoproteins and Cardiovascular HealthCardiology Journal2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.001294

17. PREVENTION OF CORONARY HEART DISEASE

    Iskandarova Shakhnoza, Amilova Asalya

    СтатьяDiabetes, Cardiovascular Risks, and LipoproteinsThe American Journal of Medical Sciences and Pharmaceutical Research2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.005361

18. Advantages of aspirin in the prevention of cardiovascular disease

    M Niladri, Gayatri Devi, Prateek Porwal +4

    СтатьяInflammatory mediators and NSAID effectsInternational Journal of Health Sciences2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.005434

19. Gender Differences in 10-Year Mortality in Patients with Coronary Artery Disease with Elevated Lipoprotein(a): In Search of Invisible Guardian Angel

    Aleksandr B. Shek, Rano B. Alieva, А. А. Абдуллаев +5

    СтатьяLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.005469

20. Polymorphism in the apolipoprotein C3 gene and coronary lesions in patients with CHD

    Р Алиева, A. Eshpulatov, Aleksandr B. Shek

    СтатьяLipoproteins and Cardiovascular HealthAtherosclerosis2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.007489

21. Clopidogrel efficacy after percutaneous coronary interventions considering with CYP2C19 genetic polymorphisms in patients with coronary heart disease

    Jamol Uzokov, B. Alyavi, A. Kh. Abdullaev +2

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.007497

22. PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis

    Ghaidaa Raheem Lateef Al‐Awsi, Methaq Hadi Lafta, Hamzah H. Kzar +9

    Обзорная статьяLipoproteins and Cardiovascular HealthInternational Immunopharmacology2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.review-article.000029

23. Cardiovascular risk prediction: from classical statistical methods to machine learning approaches

    Michela Sperti, Marta Malavolta, Federica Staunovo Polacco +6

    Обзорная статьяCardiovascular Function and Risk FactorsMinerva Cardiology and Angiology2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.review-article.000061

24. Coronary heart disease in patients with human immunodeficiency virus infection

    Amina M. Alieva, M. A. Batov, E. A. Skripnichenko +7

    СтатьяHIV-related health complications and treatmentsRussian Medicine2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.001853

25. Two approaches to modeling the risk of progressive atherosclerosis

    Н. Г. Ложкина, Yu. E. Voskoboynikov, V. N. Kopylov +2

    СтатьяHealthcare Systems and Public HealthSiberian Journal of Clinical and Experimental Medicine2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.002869